Abiopharma

🔍 Bachmann James W. (Director)

Company: Titan America SA (TTAM)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 5,880 shares of Restricted Stock Units - 2026 Grant (Derivative)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,880.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Each restricted stock unit (RSU) represents a contingent right to receive one share of Titan America SA common stock upon settlement. The RSUs vest on March 31, 2027, subject to the continued service of the Reporting Person through such vesting date. The grant is subject to forfeiture and accelerated vesting in accordance with its terms.